Errata

Article Outline

• Copyright

Errata to “Pregnancy: Maternal and Fetal Heart Disease” [Current Problems in Cardiology, 2007;32(8): 419-494]

The publisher wishes to correct an error in the source line for Table 6. The line should read: Modified from Clark SL, Cotton DB, Hankins GDV, Phelan JP, editors. Critical Care Obstetrics: Structural Cardiac Disease in Pregnancy. Cambridge, MA: Blackwell Science Publications, 1987, p. 115.

This table replaces Table 5. in Pregnancy: Maternal and Fetal Heart Disease. Curr Probl Cardiol 2007;32(8):419-494. The AHA recently issued new guidelines on antibiotic prophylaxis for labor and delivery and the updated information is presented below.

TABLE 5. Antibiotic prophylaxis for labor and delivery

Drug	Dose administered before the procedure
Amoxacillin	2gorally
Ampicillin	2gIMorIV
or
Cefazolin or ceftriaxone	1gIMorIV
Penicillin allergic
Cefalexin	2gorally
or
Clindamycin	600mgorally
or
Azithromycin or clarithromycin	500mgorally
Cefazolin or ceftriaxone	1gIMorIV
or
Clindamycin	600mgIMorIV

*Antibiotic prophylaxis is not recommended for cesarean section and vaginal delivery.

**Antibiotic prophylaxis is only recommended for prosthetic cardiac valves, previous infective endocarditis, unrepaired cyanotic CHD (palliative shunts and conduits), completely repaired CHD with prosthetic material or device within the last 6 months, and transplanted heart with valvulopathy.

Adapted from Wilson W, Taubert KA, Gewitz M, et al. Prevention of Infective Endocarditis. Guidelines from the American Heart Association. Circulation 2007;115. Available at www.circ.ahajournals.org/cgi/reprint/circulationaha.106.183095v1.